You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

December 3, 2021

Expansion of Tilleke & Gibbins M&A Team Covered by ABLJ

Asia Business Law Journal (ABLJ) has published a story on Tilleke & Gibbins’ recent addition of Derrick Khoo to the Tilleke & Gibbins regional corporate and M&A team.

As the article notes, Derrick came to Tilleke & Gibbins after several years as a general counsel handling a wide variety of international corporate legal matters. He is particularly experienced in cross-border transactions and M&A deals, growth equity investments, pre-IPO investments, corporate real estate, and other corporate and commercial legal matters.

In the article, his arrival at Tilleke & Gibbins is welcomed by Kobkit Thienpreecha, partner and director of the firm’s corporate and commercial group, who explains that Derrick is joining the firm at the same time that Thailand has been taking steps to support regional financial integration and cross-border investment opportunities. With the addition of Derrick’s expertise in these areas, Tilleke & Gibbins is broadening its capability to facilitate a greater variety and volume of these activities, in keeping with an anticipated uptick in associated transactions.

For more details on this development, please see the ABLJ website.

RELATED INSIGHTS​ 

June 25, 2012
IAM Strategy 300 has named Alan Adcock, partner and deputy director of the Tilleke & Gibbins intellectual property group, among the world’s leading IP strategists. Alan was recognized for his expertise in brokering, IP management consultancy, licensing, M&A, tax, and technology transfer, among others. Notably, Alan has been recognized for two years consecutively, as he was named in last year’s IAM Strategy 250 as well. Alan was one of just five practitioners in Southeast Asia to be recognized for his strategic expertise in IP management issues this year.
May 29, 2012
The ASEAN Economic Community (AEC), which will come into effect in 2015, will integrate the region’s economies and create a single market of 600 million consumers. All industries are bracing for this change, but the competitive landscape is transforming even more quickly in the healthcare sector. Regional harmonization has already commenced for the cosmetics industry, while further integration is imminent for other industries and products, such as medical devices.
May 29, 2012
The Thai pharmaceutical industry is characterized by its expanding yet challenging landscape. Amidst growing medical tourism and strong R&D centers in the Asia Pacific region, issues related to patent protection, counterfeit drugs, and innovation recognition are increasingly imperative for pharmaceutical companies.